A carregar...

Phase II study of VEGF trap for the treatment of metastatic thyroid cancer

BACKGROUND: Several multi-targeted tyrosine kinase inhibitors (TKIs) have activity in RAI-refractory thyroid cancer. The anti-tumor effect is attributed at least in part to their ability to inhibit angiogenesis in these vascular tumors. VEGF Trap (VT) is a recombinantly-produced fusion protein consi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer
Main Authors: Sherman, Eric J., Dunn, Lara, Ho, Alan L., Baxi, Shrujal, Ghossein, Ronald A., Haque, Sofia, Sima, Cami, Tuttle, Robert Michael, Pfister, David G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773269/
https://ncbi.nlm.nih.gov/pubmed/31174237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32046
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!